Dhaliwal Harpreet S. sold PCVX
August 5, 2026 · Form 4 insider transaction
Dhaliwal Harpreet S. sold 17,000 shares of Vaxcyte, Inc. at $55.00 per share, a transaction worth $935.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
17,000
Price
$55.00
Total value
$935.1K
InsiderDhaliwal Harpreet S.
Role—
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 5, 2026
Filing dateAugust 5, 2026
Shares owned after76,756
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026.; The price reported is a weighted-average price. The shares were sold at prices ranging from $55.00 to $55.255. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.